title: Diagnostic criteria for primary ocular lymphoma.
authors.affiliation: Massachusetts Eye Research and Surgery Institution (MERSI), Cambridge, Massachusetts; Ocular Immunology and Uveitis Foundation (OIUF), Cambridge, Massachusetts.
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Arcinue
authors.affiliation: Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital (MGH), Boston, Massachusetts.
authors.forename: Fred
authors.initials: F
authors.lastname: Hochberg
authors.affiliation: Israel (local private clinic).
authors.forename: Ron
authors.initials: R
authors.lastname: Neumann
authors.affiliation: Massachusetts Eye Research and Surgery Institution (MERSI), Cambridge, Massachusetts; Ocular Immunology and Uveitis Foundation (OIUF), Cambridge, Massachusetts; Harvard Medical School, Boston, Massachusetts.
authors.forename: C Stephen
authors.initials: CS
authors.lastname: Foster
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D016753:Interleukin-10 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D019572:Retinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D000069283:Rituximab; D014786:Vision Disorders / Q000175:diagnosis / Q000188:drug therapy; D014821:Vitrectomy; D014822:Vitreous Body / Q000378:metabolism / Q000473:pathology
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C508609:IL10 protein, human; C508600:IL6 protein, human; D007143:Immunoglobulin Heavy Chains; D015850:Interleukin-6; D016753:Interleukin-10; D000069283:Rituximab; D008727:Methotrexate